Health
Synairgen boss says SNG001 results “a clearer signal than we could have dared hope for” – Proactive Investors UK
On Monday, the company reported that patients who received its treatment had a 79% lower risk of developing severe disease compared to those given the placebo
On Monday, the company reported that patients who received its treatment had a 79% lower risk of developing severe disease compared to those given the placeboSynairgen PLCs (LON:SNG) chief executive Richard Marsden has said that the results from the companys latest trial of its SNG001 treatment for coronavirus are a clearer signal then we could have dared to hope for.
On Monday, the company reported that patients who received SNG001, an inhaled formulation of interferon beta, had a 79% lower ri…
-
Noosa News22 hours agoBrisbane’s new bus timetable sees journey times decrease by two minutes in first three months
-
Noosa News23 hours agoGovernment auditors suspected lab was conducting shonky tests on infrastructure projects
-
Business20 hours agoWhat it means for shareholders
-
Noosa News12 hours agoSchools ban e-bikes | Noosa Today